By proceeding, you agree to our Terms of Use and Privacy Policy.
Highlighting innovative technologies in diabetes The International Conference on Advanced Technologies and Treatments of Diabetes (ATTD) was established in 2008 and has held 14 annual meetings since then. The purpose of the ATTD meeting is to highlight innovative technologies in diabetes treatment.
ATDD 2022 will discuss the current scope of healthcare in fighting diabetes as a disease and the technology that can help in this mission.
ATDD 2022 will act as a platform to present ideas, discuss points and learn new things when it comes to trends in technology against diabetes.
Patient care, new healthcare opportunities and the fight against diabetes will be a few topics that the keynote speakers and guest speakers will speak upon.
15-17 April 2024
Join us at the Festival of Biologics USA 2024, the most exciting biologics event in America! Taking place from April 15 to 17, 2024, at the renowned San Diego Convention Center, this three-day event will cover the entire journey of biologic drug deve
Event Started
USA
Paid
San Diego
18-19 April 2024
Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.
Starts in 2 days
Boston
Our Mission: To be the world’s leading facilitator of meetings for global exchange of professional knowledge in medical, scientific and other professions, based upon our core values of integrity and excellence.
A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.
Abbott is a global healthcare leader that helps people live more fully at all stages of life.
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes.
For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of disease, and
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.